GNH India Completes 200 Successful Audits

/ -- A global source for priority medicines, GNH India Pharmaceuticals Ltd., has completed 200 successful audits with its last audit conducted from USA.

GNH India was audited by an organization from the USA on 26th July, 2018, which marked the 200th quality audit. These audits are an independent and systematic examination to determine whether activities and related results comply with planned arrangements and the effective implementation of the same arrangements. With the 200th audit, GNH India now stands as the only merchant exporter to be audited by government agencies, multinational companies and clinical trial organizations from all five continents.

On this achievement, Dr. Piyush Gupta, Director, GNH India, remarked, "Audits stand as a medium to ascertain the validity and reliability of the information and details claimed by an organization. GNH India has always proven to hold its flag high when it comes to the assessment of its internal system and services to provide aid to the patients all over the world."
About GNH India